The Study of Different Dose Rituximab in the Treatment of ITP
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University in China. In order to
compare the efficacy, safety and response duration of different dose of rituximab in patients
primary immune thrombocytopenia(pITP).